Sort   by:  
 Page size 
UnknownFirst-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial.
Not available
S-EPMC3488187 | biostudies-literature
UnknownThe impact of smoking cessation on multiple sclerosis disease progression.
Not available
S-EPMC9128822 | biostudies-literature
UnknownThe National Lung Matrix Trial of personalized therapy in lung cancer.
Not available
S-EPMC7116732 | biostudies-literature
UnknownGenomic Diagnosis of Rare Pediatric Disease in the United Kingdom and Ireland.
Not available
S-EPMC7614484 | biostudies-literature
UnknownAdjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.
Not available
S-EPMC6096737 | biostudies-literature
UnknownFinding Diagnostically Useful Patterns in Quantitative Phenotypic Data.
Not available
S-EPMC6848993 | biostudies-literature
UnknownLarge-scale discovery of novel genetic causes of developmental disorders.
Not available
S-EPMC5955210 | biostudies-literature
UnknownQuantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants.
Not available
S-EPMC8896276 | biostudies-literature
UnknownMetformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861 | biostudies-literature
UnknownCHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language.
Not available
S-EPMC6218476 | biostudies-literature
Sort   by:  
 Page size